Detalles de la búsqueda
1.
NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats.
Elife
; 112022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35234610
2.
Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity.
J Gen Physiol
; 153(5)2021 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836525
3.
Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310.
J Med Chem
; 64(6): 2953-2966, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682420
4.
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective NaV1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy.
J Med Chem
; 62(21): 9618-9641, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31525968
5.
Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity.
J Med Chem
; 62(2): 908-927, 2019 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30499663
6.
Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain.
Cell Rep
; 24(12): 3133-3145, 2018 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231997
7.
Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain.
J Med Chem
; 61(11): 4810-4831, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29737846
Resultados
1 -
7
de 7
1
Próxima >
>>